Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001070081-20-000097
Filing Date
2020-05-07
Accepted
2020-05-07 15:44:46
Documents
1
Period of Report
2020-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158888066893504.html 4  
1 FORM 4 wf-form4_158888066893504.xml 4 24541
  Complete submission text file 0001070081-20-000097.txt   26018
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Business Address
Peltz Stuart Walter (Reporting) CIK: 0001578962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35969 | Film No.: 20856101